Inhibition of Inflammation by a p38 MAP Kinase Targeted Cell Permeable Peptide

E-ISSN： 1875-6638|4|6|597-604

ISSN： 1573-4064

Source： Medicinal Chemistry, Vol.4, Iss.6, 2008-11, pp. : 597-604

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cell-targeted p38 inhibitors

By Norman Peter

Expert Opinion on Therapeutic Patents, Vol. 18, Iss. 7, 2008-07 ,pp. : 805-809

Informa Healthcare

Access to resources Recommend Favorite

Pathway to the Clinic: Inhibition of P38 MAP Kinase. A Review of Ten Chemotypes Selected for Development

Current Topics in Medicinal Chemistry, Vol. 5, Iss. 10, 2005-09 ,pp. : 1017-1029

Bentham Science Publishers

Access to resources Recommend Favorite

Pyridinylimidazole Based p38 MAP Kinase Inhibitors

Current Topics in Medicinal Chemistry, Vol. 2, Iss. 9, 2002-09 ,pp. : 1011-1020

Bentham Science Publishers

Access to resources Recommend Favorite

The Biology of p38 Kinase: A Central Role in Inflammation

Current Topics in Medicinal Chemistry, Vol. 5, Iss. 10, 2005-09 ,pp. : 921-928

Bentham Science Publishers

Access to resources Recommend Favorite

The Non-Diaryl Heterocycle Classes of p38 MAP Kinase Inhibitors

Current Topics in Medicinal Chemistry, Vol. 2, Iss. 9, 2002-09 ,pp. : 1021-1035

Bentham Science Publishers

Access to resources Recommend Favorite